Skip to content
The U.S. biotech sector is a vital economic engine in all 50 states, providing 2.1 million jobs and a $2.9 trillion impact on the […]
U.S. biotech is a major economic driver with a broad range, report says Read More »
The flu season is upon us and now is the time to get your flu vaccine. “About 5% to 20% of the U.S. population
CDC offers help in choosing a vaccine as flu season arrives Read More »
According to a new observational study, there is a possible association between exposure to aluminum adjuvants in childhood vaccines and the development of persistent
CDC advises no change for vaccines with aluminum adjuvants Read More »
Policymakers and public health leaders have been playing a dangerous game when it comes to how they are preparing, or rather are not preparing,
Shionogi shows how a biotech firm can tackle AMR Read More »
When the World Trade Organization (WTO) agreed to waive patent protections for COVID-19 vaccines in June, the organization claimed the agreement “proved that WTO
Ignoring industry efforts and market risks, WTO considers another IP waiver Read More »
Nucleic acid and gene therapies are the future of medicine. However, current delivery methods pose many limitations when it comes to getting potential therapies
The Inflation Reduction Act, passed August 7, 2022, will hit biotech innovation hard by enacting drug price controls on around 100 drugs over the
Who the Inflation Reduction Act helps Read More »
Congress needs to ensure the smooth continuation of two federal programs that provide seed funding for small, innovative businesses, according to a host of
SBIR/STTR seed-funding programs running out of money – and Congress needs to act Read More »
A new bacteria has made a home in the Gulf Coast region and scientists are not happy. Burkholderia pseudomallei is typically endemic to much
Deadly bacteria found for the first time on the Gulf Coast – and it won’t be the last Read More »
In a $5.4 billion deal that will boost its rare disease treatment business, Pfizer is buying the pioneer in treatments for sickle cell disease,
Global Blood Therapeutics acquisition to boost Pfizer’s sickle cell pipeline Read More »
